Incontinence treatment transforming lives worldwide

The use of Botox worldwide for the treatment of overactive bladder and incontinence.


What is an overactive bladder?

Overactive bladder (OAB) affects 1 in 8 people, yet it’s rarely spoken about. Someone with OAB cannot hold their bladder and might need to rush to the toilet at any time.

Our role

In 2005, Mr Arun Sahai received funding from The Urology Foundation to explore using Botox to treat patients with OAB. He ran the world’s first level 1 double-blind placebo-controlled trial of Botox as a treatment for idiopathic OAB.

Global impact

Botox now appears as standard of care in all international guidelines for managing OAB, meaning that millions of people across the globe have access to effective treatment for a debilitating condition.

£1 box

Get involved

Whether it's funding research, supporting urology healthcare professionals, raising awareness of urology health or campaigning, we couldn't do it without your support

Ways to make a difference

All the work we do to fight urology disease is funded by supporters across the country. We can only continue our vital work with support from people like you.

When you donate to The Urology Foundation you join the front line of the fight against urology disease. Your money helps us to:

  • Invest in ground breaking research into urology diseases so that we can find better cures and treatments
  • Provide training and education to equip all urology professionals with the tools they need to support and treat patients in hospitals across the UK and Ireland
  • Drive change based on research outcomes